VF
SNTI icon

Virtu Financial’s Senti Biosciences Holdings SNTI Stock Holding History

Virtu Financial’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,409
Closed -$46K – 2252
2025
Q4 		$46K Buy
+44,409
New +$78.5K ﹤0.01% 1319
2025
Q1 		– Sell
-13,356
Closed -$47K – 1987
2024
Q4 		$47K Buy
+13,356
New +$42.6K ﹤0.01% 1172
2024
Q2 		– Sell
-1,968
Closed -$7K – 1841
2024
Q1 		$7K Buy
+1,968
New +$8.8K ﹤0.01% 1276
2023
Q3 		– Sell
-3,470
Closed -$22K – 1854
2023
Q2 		$22K Buy
+3,470
New +$33.9K ﹤0.01% 1247
2022
Q3 		– Sell
-2,203
Closed -$43K – 2204
2022
Q2 		$43K Buy
+2,203
New +$177K ﹤0.01% 1161

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial's SNTI Position: Q1 2026 in Review

Virtu Financial sold out of Senti Biosciences Holdings (SNTI) in Q1 2026, closing a stake of 44,409 shares — an estimated $46K sold.

Virtu Financial first reported a position in SNTI in Q2 2022 and held it in 5 quarters. The position peaked at $47K in Q4 2024. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Virtu Financial reported no remaining Senti Biosciences Holdings position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 44,409 Senti Biosciences Holdings shares in Q1 2026, an estimated $46K.
  • Virtu Financial first reported a position in Senti Biosciences Holdings in Q2 2022 and held it in 5 quarters.
  • Virtu Financial's Senti Biosciences Holdings position peaked at $47K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.